01
Overview Janssen has a broad pipeline with 50+ clinical programs spanning immune, infectious, cardiovascular, oncology, neuroscience, metabolic, and rare diseases; several drugs have achieved global regulatory approval including breakthrough therapies for HIV/AIDS, cancer, and autoimmune disorders.
Therapeutic areas Immunology Cardiovascular Endocrinology Neurology Infectious Diseases Pulmonology Rheumatology Rare Diseases Oncology Ophthalmology
Modalities Small molecule Monoclonal antibody Antibody-drug conjugate Biologic Vaccine Gene therapy RNA therapy Peptides Recombinant protein Cell therapy
Industry Pharma 02
Partnerships KU Leuven Rega Institute (JNJ-1802 collaboration) Mitsubishi Tanabe Pharma (INVOKANA, etc.) Bayer Healthcare (XARELTO) Amgen (PROCRIT/EPREX) MeiraGTx (AAV-RPGR gene therapy) Bristol Myers Squibb (milvexian) Pharmacyclics/AbbVie (IMBRUVICA) BTG (ZYTIGA) Millennium/Takeda (VELCADE) Genmab (DARZALEX) Astex Pharmaceuticals (BALVERSA) Regents of California / MSK (ERLEADA) Pipeline Therapeutics (PIPE-307) Locus Biosciences (CRISPR platform)
How Gosset builds this profile → Beyond the preview
Go deeper on Janssen Pharmaceutica. Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials Unlock Clinical trials with a free account Follow clinical development from trial design and recruitment through results.
Trial phase Status Readouts Licensing & deals Unlock Licensing & deals with a free account Explore licensing agreements, acquisitions, and the assets behind each deal.
Partners Deal terms Milestones Funding history Unlock Funding history with a free account Trace financing activity and the investors behind a company’s development.
Funding rounds Investors Capital raised Competitive landscape Unlock Competitive landscape with a free account Compare peer pipelines by target, modality, and therapeutic area.
Peer companies Targets Pipeline overlap Technologies & patents Unlock Technologies & patents with a free account Explore technology platforms and the patent landscape around relevant assets.
Platforms Patents Assignees Research & analysis Unlock Research & analysis with a free account Connect company news and source material to the questions you’re investigating.
Company news Sources Analysis Bring the full picture into focus. See how Gosset can support your research on Janssen Pharmaceutica.
Explore the full profile